Study of Axonics SNM System to Treat Overactive Bladder in Men with Prostate or BPH Surgery History

What this Trial Is About

This research aims to evaluate the clinical outcomes of the Axonics Sacral Neuromodulation SNM System for treating overactive bladder in male patients. It focuses on men with a history of radical prostatectomy or radiation therapy for prostate cancer, or those who have undergone surgery for benign prostatic hyperplasia BPH. The study is designed to assess how the device performs and its safety in this specific population. Participants will receive the Axonics SNM System, a device being studied for its effects on overactive bladder symptoms such as urinary urgency incontinence and urinary frequency. Eligible men will have had their prior prostate-related treatments at least six months before enrollment. The study uses a single-group design, monitoring outcomes over one year to assess effectiveness and safety. Throughout the study, participants will complete bladder diaries and questionnaires to track symptom changes and quality of life improvements. Researchers will monitor adverse events and measure reductions in urinary episodes at 6 months and 1 year. Participants are expected to attend all follow-up visits during this period to support thorough evaluation of the devices impact and safety.

Sacral Neuromodulation for Male Overactive Bladder (MOAB)